SUBSCRIBE
SUBSCRIBE

MAIA Biotechnology

IN THE PRESS
Press Releases
MAIA Biotechnology Highlights Positive Efficacy Data from THIO-101 Phase 2 Clinical Trial in Non-Small Cell Lung Cancer
September 12, 2025
 · 
6 min read
Press Releases
MAIA Biotechnology Abstract Selected for Poster Presentation at 2025 IASLC World Conference on Lung Cancer
September 8, 2025
 · 
7 min read
Press Releases
MAIA Biotechnology Announces Publication of Interim Clinical Data on Telomere Targeting Anticancer Agent in Peer-Reviewed Journal Cells
August 28, 2025
 · 
5 min read
Press Releases
MAIA Biotechnology Granted European Patent for Next Generation Telomere-Targeting Agents for Cancer Therapy
August 14, 2025
 · 
5 min read
Press Releases
MAIA Biotechnology Receives FDA’s Fast Track Designation for Ateganosine as a Treatment for Non-Small Cell Lung Cancer
July 28, 2025
 · 
7 min read
Press Releases
MAIA Biotechnology Announces Peer-Reviewed Journal Publication of Data Validating Second Generation Ateganosine Prodrugs for Anticancer Therapy
July 18, 2025
 · 
5 min read
Press Releases
MAIA Biotechnology Announces First Patient Dosed in Expansion of Phase 2 Trial for Ateganosine in Advanced Non-Small Cell Lung Cancer
July 9, 2025
 · 
6 min read
Press Releases
MAIA Biotechnology to Present Two Posters Featuring Cancer Telomere-Targeting Agents at FEBS 2025 Congress
July 1, 2025
 · 
6 min read
Press Releases
MAIA Biotechnology Welcomes Leading Hepatocellular Carcinoma Clinician-Scientists to Scientific Advisory Board
June 24, 2025
 · 
7 min read
Press Releases
MAIA Biotechnology Announces Master Clinical Supply Agreement with Roche for Hard-to-Treat Cancer Therapies
June 18, 2025
 · 
4 min read
Load More
JOBS